Bromine in PDB 4z83: PKAB3 in Complex with Pyrrolidine Inhibitor 47A
Enzymatic activity of PKAB3 in Complex with Pyrrolidine Inhibitor 47A
All present enzymatic activity of PKAB3 in Complex with Pyrrolidine Inhibitor 47A:
2.7.11.11;
Protein crystallography data
The structure of PKAB3 in Complex with Pyrrolidine Inhibitor 47A, PDB code: 4z83
was solved by
B.A.Lund,
K.A.Alam,
R.A.Engh,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.61 /
1.80
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
82.575,
61.491,
78.948,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18 /
21.8
|
Bromine Binding Sites:
The binding sites of Bromine atom in the PKAB3 in Complex with Pyrrolidine Inhibitor 47A
(pdb code 4z83). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 3 binding sites of Bromine where determined in the
PKAB3 in Complex with Pyrrolidine Inhibitor 47A, PDB code: 4z83:
Jump to Bromine binding site number:
1;
2;
3;
Bromine binding site 1 out
of 3 in 4z83
Go back to
Bromine Binding Sites List in 4z83
Bromine binding site 1 out
of 3 in the PKAB3 in Complex with Pyrrolidine Inhibitor 47A
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of PKAB3 in Complex with Pyrrolidine Inhibitor 47A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Br401
b:54.1
occ:0.27
|
BR
|
E:4L7401
|
0.0
|
54.1
|
0.3
|
C
|
E:4L7401
|
1.9
|
35.6
|
1.0
|
BR
|
E:4L7401
|
1.9
|
77.5
|
0.7
|
HA3
|
E:GLY52
|
2.9
|
26.2
|
1.0
|
C1
|
E:4L7401
|
2.9
|
40.5
|
1.0
|
S
|
E:4L7401
|
3.1
|
28.7
|
1.0
|
HA3
|
E:GLY55
|
3.1
|
37.5
|
1.0
|
H
|
E:4L7401
|
3.1
|
48.5
|
1.0
|
C
|
E:GLY55
|
3.3
|
30.4
|
1.0
|
H
|
E:GLY55
|
3.3
|
30.1
|
1.0
|
HD22
|
E:LEU74
|
3.4
|
32.5
|
1.0
|
O
|
E:GLY55
|
3.4
|
28.0
|
1.0
|
N
|
E:GLY55
|
3.4
|
28.0
|
1.0
|
CA
|
E:GLY55
|
3.4
|
31.5
|
1.0
|
HD23
|
E:LEU74
|
3.5
|
32.5
|
1.0
|
HD21
|
E:LEU74
|
3.5
|
32.5
|
1.0
|
CA
|
E:GLY52
|
3.6
|
24.5
|
1.0
|
CD2
|
E:LEU74
|
3.6
|
25.7
|
1.0
|
H
|
E:PHE54
|
3.7
|
33.5
|
1.0
|
H
|
E:GLY52
|
3.8
|
32.6
|
1.0
|
N
|
E:GLY52
|
3.9
|
27.6
|
1.0
|
N
|
E:ARG56
|
3.9
|
29.1
|
1.0
|
C
|
E:PHE54
|
4.1
|
29.6
|
1.0
|
O
|
E:HOH744
|
4.1
|
41.2
|
1.0
|
C2
|
E:4L7401
|
4.1
|
31.4
|
1.0
|
C
|
E:GLY52
|
4.1
|
26.5
|
1.0
|
HD3
|
E:LYS72
|
4.2
|
43.2
|
1.0
|
H
|
E:ARG56
|
4.2
|
33.6
|
1.0
|
HA
|
E:ARG56
|
4.2
|
31.3
|
1.0
|
C3
|
E:4L7401
|
4.3
|
26.8
|
1.0
|
HD1
|
E:PHE54
|
4.3
|
30.0
|
1.0
|
CD1
|
E:PHE54
|
4.4
|
28.0
|
1.0
|
HA2
|
E:GLY55
|
4.4
|
37.5
|
1.0
|
N
|
E:PHE54
|
4.4
|
29.4
|
1.0
|
HA2
|
E:GLY52
|
4.4
|
26.2
|
1.0
|
H
|
E:SER53
|
4.4
|
36.1
|
1.0
|
CE1
|
E:PHE54
|
4.5
|
33.5
|
1.0
|
HE1
|
E:PHE54
|
4.5
|
42.3
|
1.0
|
HG3
|
E:LYS72
|
4.5
|
28.2
|
1.0
|
N
|
E:SER53
|
4.5
|
32.2
|
1.0
|
CA
|
E:ARG56
|
4.6
|
28.1
|
1.0
|
O
|
E:HOH758
|
4.6
|
49.8
|
1.0
|
O
|
E:PHE54
|
4.6
|
30.6
|
1.0
|
C
|
E:THR51
|
4.6
|
35.7
|
1.0
|
O
|
E:GLY52
|
4.7
|
29.5
|
1.0
|
CA
|
E:PHE54
|
4.8
|
36.6
|
1.0
|
HZ2
|
E:LYS72
|
4.8
|
52.5
|
1.0
|
CG
|
E:PHE54
|
4.9
|
33.3
|
1.0
|
HA
|
E:THR51
|
4.9
|
37.0
|
1.0
|
HG2
|
E:LYS72
|
5.0
|
28.2
|
1.0
|
CD
|
E:LYS72
|
5.0
|
32.2
|
1.0
|
|
Bromine binding site 2 out
of 3 in 4z83
Go back to
Bromine Binding Sites List in 4z83
Bromine binding site 2 out
of 3 in the PKAB3 in Complex with Pyrrolidine Inhibitor 47A
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of PKAB3 in Complex with Pyrrolidine Inhibitor 47A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Br401
b:77.5
occ:0.73
|
BR
|
E:4L7401
|
0.0
|
77.5
|
0.7
|
BR
|
E:4L7401
|
1.9
|
54.1
|
0.3
|
H
|
E:PHE54
|
2.4
|
33.5
|
1.0
|
HA3
|
E:GLY52
|
2.6
|
26.2
|
1.0
|
H
|
E:SER53
|
3.0
|
36.1
|
1.0
|
O
|
E:HOH758
|
3.1
|
49.8
|
1.0
|
C
|
E:4L7401
|
3.2
|
35.6
|
1.0
|
N
|
E:PHE54
|
3.3
|
29.4
|
1.0
|
N
|
E:SER53
|
3.3
|
32.2
|
1.0
|
CA
|
E:GLY52
|
3.4
|
24.5
|
1.0
|
H
|
E:GLY55
|
3.5
|
30.1
|
1.0
|
C
|
E:GLY52
|
3.5
|
26.5
|
1.0
|
CD1
|
E:PHE54
|
3.5
|
28.0
|
1.0
|
CE1
|
E:PHE54
|
3.6
|
33.5
|
1.0
|
H
|
E:4L7401
|
3.6
|
48.5
|
1.0
|
CG
|
E:PHE54
|
3.7
|
33.3
|
1.0
|
N
|
E:GLY55
|
3.7
|
28.0
|
1.0
|
CZ
|
E:PHE54
|
3.8
|
34.4
|
1.0
|
C1
|
E:4L7401
|
3.8
|
40.5
|
1.0
|
CD2
|
E:PHE54
|
3.8
|
39.7
|
1.0
|
HD1
|
E:PHE54
|
3.8
|
30.0
|
1.0
|
CE2
|
E:PHE54
|
3.9
|
33.6
|
1.0
|
HE1
|
E:PHE54
|
3.9
|
42.3
|
1.0
|
C
|
E:PHE54
|
4.0
|
29.6
|
1.0
|
HD23
|
E:LEU74
|
4.0
|
32.5
|
1.0
|
CA
|
E:PHE54
|
4.0
|
36.6
|
1.0
|
HA2
|
E:GLY52
|
4.0
|
26.2
|
1.0
|
O
|
E:HOH744
|
4.0
|
41.2
|
1.0
|
OG
|
E:SER53
|
4.1
|
34.7
|
0.7
|
HZ
|
E:PHE54
|
4.2
|
44.5
|
1.0
|
HA3
|
E:GLY55
|
4.2
|
37.5
|
1.0
|
C
|
E:SER53
|
4.3
|
36.5
|
1.0
|
CA
|
E:SER53
|
4.3
|
35.6
|
1.0
|
N
|
E:GLY52
|
4.3
|
27.6
|
1.0
|
O
|
E:GLY52
|
4.3
|
29.5
|
1.0
|
HD2
|
E:PHE54
|
4.4
|
55.5
|
1.0
|
H
|
E:GLY52
|
4.4
|
32.6
|
1.0
|
HD22
|
E:LEU74
|
4.4
|
32.5
|
1.0
|
CA
|
E:GLY55
|
4.4
|
31.5
|
1.0
|
HE2
|
E:PHE54
|
4.4
|
42.9
|
1.0
|
CB
|
E:PHE54
|
4.4
|
28.5
|
1.0
|
O
|
E:GLY55
|
4.5
|
28.0
|
1.0
|
CD2
|
E:LEU74
|
4.5
|
25.7
|
1.0
|
S
|
E:4L7401
|
4.6
|
28.7
|
1.0
|
C
|
E:GLY55
|
4.6
|
30.4
|
1.0
|
HD21
|
E:LEU74
|
4.7
|
32.5
|
1.0
|
O
|
E:PHE54
|
4.7
|
30.6
|
1.0
|
HG
|
E:SER53
|
4.8
|
41.6
|
0.7
|
CB
|
E:SER53
|
4.8
|
35.2
|
0.9
|
HA
|
E:PHE54
|
4.9
|
48.2
|
1.0
|
|
Bromine binding site 3 out
of 3 in 4z83
Go back to
Bromine Binding Sites List in 4z83
Bromine binding site 3 out
of 3 in the PKAB3 in Complex with Pyrrolidine Inhibitor 47A
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of PKAB3 in Complex with Pyrrolidine Inhibitor 47A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Br402
b:28.8
occ:0.80
|
BR
|
E:4L7402
|
0.0
|
28.8
|
0.8
|
C
|
E:4L7402
|
1.9
|
30.5
|
0.9
|
C1
|
E:4L7402
|
2.9
|
32.4
|
0.8
|
HZ
|
E:PHE100
|
3.0
|
27.6
|
1.0
|
HB3
|
E:GLU155
|
3.1
|
30.5
|
1.0
|
S
|
E:4L7402
|
3.1
|
39.5
|
1.0
|
H
|
E:4L7402
|
3.1
|
38.8
|
0.8
|
O
|
E:LEU152
|
3.1
|
19.8
|
1.0
|
HB2
|
E:TYR156
|
3.4
|
30.1
|
1.0
|
HD23
|
E:LEU152
|
3.4
|
39.9
|
1.0
|
HB3
|
E:LEU152
|
3.4
|
23.1
|
1.0
|
HE1
|
E:PHE100
|
3.4
|
33.5
|
1.0
|
OE1
|
E:GLU155
|
3.5
|
28.7
|
1.0
|
CZ
|
E:PHE100
|
3.6
|
23.8
|
1.0
|
HA
|
E:LEU152
|
3.6
|
22.3
|
1.0
|
H
|
E:TYR156
|
3.7
|
23.5
|
1.0
|
HG2
|
E:GLU155
|
3.7
|
28.1
|
1.0
|
CD
|
E:GLU155
|
3.8
|
33.1
|
1.0
|
CE1
|
E:PHE100
|
3.8
|
27.0
|
1.0
|
HD23
|
E:LEU19
|
3.8
|
46.4
|
1.0
|
CB
|
E:GLU155
|
3.9
|
25.6
|
1.0
|
C
|
E:LEU152
|
3.9
|
19.3
|
1.0
|
N
|
E:TYR156
|
4.0
|
20.1
|
1.0
|
HD21
|
E:LEU152
|
4.0
|
39.9
|
1.0
|
CG
|
E:GLU155
|
4.0
|
24.9
|
1.0
|
CA
|
E:LEU152
|
4.1
|
19.5
|
1.0
|
C2
|
E:4L7402
|
4.1
|
32.8
|
0.8
|
CD2
|
E:LEU152
|
4.1
|
28.2
|
1.0
|
CB
|
E:LEU152
|
4.1
|
20.0
|
1.0
|
CB
|
E:TYR156
|
4.2
|
23.6
|
1.0
|
HA
|
E:TYR156
|
4.2
|
33.8
|
1.0
|
C3
|
E:4L7402
|
4.3
|
27.1
|
1.0
|
CA
|
E:TYR156
|
4.4
|
25.1
|
1.0
|
OE2
|
E:GLU155
|
4.4
|
33.4
|
1.0
|
HE2
|
E:PHE18
|
4.4
|
46.8
|
1.0
|
HB3
|
E:TYR156
|
4.5
|
30.1
|
1.0
|
HB2
|
E:GLU155
|
4.5
|
30.5
|
1.0
|
C
|
E:GLU155
|
4.6
|
21.9
|
1.0
|
CE2
|
E:PHE100
|
4.7
|
24.6
|
1.0
|
CG
|
E:LEU152
|
4.7
|
21.7
|
1.0
|
CD2
|
E:LEU19
|
4.8
|
35.2
|
1.0
|
HZ1
|
E:LYS292
|
4.8
|
38.8
|
1.0
|
CA
|
E:GLU155
|
4.8
|
26.2
|
1.0
|
HD22
|
E:LEU152
|
4.9
|
39.9
|
1.0
|
HB2
|
E:LEU152
|
4.9
|
23.1
|
1.0
|
HD22
|
E:LEU19
|
4.9
|
46.4
|
1.0
|
HE2
|
E:PHE100
|
4.9
|
30.0
|
1.0
|
HG3
|
E:GLU155
|
5.0
|
28.1
|
1.0
|
HD12
|
E:LEU152
|
5.0
|
28.4
|
1.0
|
HD1
|
E:TYR156
|
5.0
|
31.4
|
1.0
|
|
Reference:
B.S.Lauber,
L.A.Hardegger,
A.K.Asraful,
B.A.Lund,
O.Dumele,
M.Harder,
B.Kuhn,
R.A.Engh,
F.Diederich.
Addressing the Glycine-Rich Loop of Protein Kinases By A Multi-Facetted Interaction Network: Inhibition of Pka and A Pkb Mimic. Chemistry V. 22 211 2016.
ISSN: ISSN 0947-6539
PubMed: 26578105
DOI: 10.1002/CHEM.201503552
Page generated: Wed Jul 10 23:09:17 2024
|